Physician profile
Said Mohammad
NPI 1659012722
$435.80
in general payments reported to CMS, 2019-2025
10 companies · $53.61 in 2025
The $53.61 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $169 · 2024: $214 · 2025: $53.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $267.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $193.95 | 2024 | Lybalvi, Aristada, Aristada Initio |
| Abbvie INC. | $53.56 | 2022-2025 | |
| Almatica Pharma LLC | $38.26 | 2022 | |
| Janssen Pharmaceuticals, INC | $30.22 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.46 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $21.22 | 2022 | |
| Braeburn INC. | $20.47 | 2025 | Brixadi |
| Indivior INC. | $19.70 | 2024 | Sublocade |
| Lilly USA, LLC | $19.23 | 2025 | Zepbound |
| Lundbeck LLC | $17.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Said Mohammad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.